// company-profile
ARS Pharmaceuticals, Inc.
SPRY// activity-summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares (net $38K). Buying was led by Karas Eric.
// 90-day insight
Over the last 90 days, ARS Pharmaceuticals, Inc. insiders bought $38K across 2 transactions with no open-market sales.
- Most active insider: Karas Eric with 3 transactions totaling $288K.
- Largest single sale: $250K by Karas Eric on Jun 12, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of ARS Pharmaceuticals, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Karas Eric | SPRY | Option Exercise | 25,000 | $0.00 | $0K |
| Jun 12, 2026 | Karas Eric | SPRY | Option Exercise | 25,000 | $1.50 | $38K |
| Jun 12, 2026 | Karas Eric | SPRY | Sale10b5 | 25,000 | $10.00 | $250K |
| Jun 12, 2026 | Fitzpatrick Alexander A | SPRY | Sale10b5 | 3,355 | $10.00 | $34K |
| Jan 2, 2026 | Dorsey Brian | SPRY | Award | 240,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.